Physician profile
Michael Arno
NPI 1235528951
$1,084.57
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,028 · 2022: $56.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.09 | 2021 | |
| Medtronic, INC. | $184.75 | 2021-2022 | |
| Edwards Lifesciences Corporation | $164.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.34 | 2021 | |
| Amgen INC. | $90.48 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $40.06 | 2021 | |
| Novo Nordisk INC | $38.31 | 2021 | |
| Boston Scientific Corporation | $37.03 | 2021 | |
| Akcea Therapeutics, INC. | $26.56 | 2021 | |
| Pfizer INC. | $23.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.07 | 2021 | |
| Lundbeck LLC | $21.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.11 | 2021 | |
| Abbott Laboratories | $15.61 | 2021 | |
| Abbvie INC. | $14.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| G Medical Diagnostic Services, INC. | $13.01 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Arno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.